Need professional-grade analysis? Visit stockanalysis.com
$47.26M
N/A
N/A
N/A
Vicapsys Life Sciences Inc (VICP) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $1.46.
Over the past year, VICP has traded between a low of $0.51 and a high of $1.77. The stock has lost 17.5% over this period. It is currently 17.5% below its 52-week high.
Vicapsys Life Sciences Inc has a market capitalization of $47.26M.
Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.
Side-by-side comparison against top Healthcare peers.